Investing Profile
Andrew Bayliffe
Your Intro Paths to Andrew Bayliffe
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Andrew is a member of
University of Leeds Network
33 CONNECTIONS
GSK Network
32 CONNECTIONS
GSK Network
32 CONNECTIONS
GSK Network
32 CONNECTIONS
GSK Network
32 CONNECTIONS
Find Andrew Bayliffe on
cbCurrent Investing Position
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
1
Andrew Bayliffe is on these Sector & Stage Rankings
Andrew Bayliffe's Investments On Record (1)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Marengo Therapeutics | Series BNov 2021$80M | $80M |
Andrew Bayliffe's Experience
Chief Scientific Officer Marengo Therapeutics2020 - Present
Venture Partner Apple Tree Partners2019 - Present
Head, Respiratory and Inflammation Research Unit GSK2015 - 2020
Global Development Leader - Respiratory & Inflammation GSK2013 - 2015
Head, Translational Medicine - Biopharmaceuticals Innovation Unit GSK2011 - 2013
Clinical Pharmacology Leader - Biopharmaceuticals R&D GSK2008 - 2011
Clinical Pharmacology Leader - Immunology & Inflammation R&D GSK2004 - 2008
Translational Scientist - Clinical Pharmacology & Experimental Medicine GSK2002 - 2004
Research Scientist, Pharmacogenetics & Applied Diagnostics GSK2000 - 2002
Research Scientist AstraZeneca1998 - 2000
Andrew Bayliffe's Education
The Manchester Metropolitan University Bachelor of Science - BS Pharmacology
University of Leeds Doctor of Philosophy - PhD Pharmacology and Molecular Biology
Investors who invest with Andrew Bayliffe
Founders who looked at Andrew Bayliffe's profile also looked at these Scouts & Angels